U.S. officials bet on Novavax to provide a shot that could easily be shipped overseas. But its manufacturing problems have left global distributors without enough shots for poor and middle-income countries. POLITICO's Erin Banco reports.
U.S. officials bet on Novavax to provide a shot that could easily be shipped overseas. But its manufacturing problems have left global distributors without enough shots for poor and middle-income countries. POLITICO's Erin Banco reports.